Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Valsoia S.p.A. is an Italian company specializing in the production and marketing of plant-based and health-oriented food products. Founded in 1990 and headquartered in Bologna, it leads the market in soy-based alternatives and has expanded into diverse plant sources like oat, rice, almond, coconut, and cashew. The company offers a broad portfolio including dairy-free drinks, ice creams, yogurts, desserts, biscuits, ready meals, cheeses, condiments, preserves, fruit products, and tomato sauces under brands such as Valsoia, Santa Rosa, Pomodorissimo, Vitasoya, and others. Valsoia emphasizes innovation through substantial R&D investments, focusing on functional foods that provide health benefits beyond basic nutrition, while prioritizing high-quality ingredients, sustainable practices, and flavor development to align with Italian dietary traditions. Operating primarily in Italy with growing international presence, it serves families seeking healthy, vegan, and vegetarian options for daily consumption from breakfast to dinner. In the consumer defensive sector's packaged foods industry, Valsoia contributes to shifting dietary habits toward wellness and plant-based eating, employing around 192 people under CEO Andrea Panzani.
€10.00
€0.10 (-0.99%)
EOD Jun 23, 2026 · Twelve Data
Operating margin is thin at 7.83%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 3.5%, steady but not accelerating. Free cash flow declined 14% despite revenue growth, conversion is weakening.
Free cash flow declined 14% versus the prior year, cash generation momentum has weakened.
13.1x earnings, 27.1x FCF. The multiple is below average. Either the market is pricing in deterioration you should investigate, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€117M
▲ +3.5% YoY
Net Income (TTM)
€8M
▲ +15.9% YoY
Op. Margin
7.83%
▲ +1.2pp YoY
ROIC
6.67%
▲ +1.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€4M
▼ -14.0% YoY
Op. Cash Flow (TTM)
€8M
▲ +29.9% YoY
Net Debt
-€9M
Net Cash Position
Cash & Equiv.
€16M
3Y CAGR: +8.7%
3Y CAGR: -24.3%
Continue Research